Cargando…
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Since its discovery in 1984, the beta amyloid peptide has treaded the boards of neurosciences as the star molecule in Alzheimer’s disease pathogenesis. In the last decade, however, this vision has been challenged by evidence-based medicine showing the almost complete failure of clinical trials that...
Autores principales: | Ricciarelli, Roberta, Fedele, Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652035/ https://www.ncbi.nlm.nih.gov/pubmed/28093977 http://dx.doi.org/10.2174/1570159X15666170116143743 |
Ejemplares similares
-
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
por: Fedele, Ernesto
Publicado: (2023) -
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
por: Kurkinen, Markku, et al.
Publicado: (2023) -
Memory Enhancers for Alzheimer’s Dementia: Focus on cGMP
por: Fedele, Ernesto, et al.
Publicado: (2021) -
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
por: Reitz, Christiane
Publicado: (2012) -
The Pathogenesis of Alzheimer's Disease: A Reevaluation of the “Amyloid Cascade Hypothesis”
por: Armstrong, R. A.
Publicado: (2011)